Recent IONS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 10:15:03 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 02:06:32 PM
- Ionis partner Biogen announces topline results from Phase 2 CELIA study of diranersen (BIIB080): first study to show reduction in tau pathology and cognitive benefit in patients with early Alzheimer’s disease • Business Wire • 05/14/2026 11:05:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:20:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:30:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/04/2026 10:05:52 PM
- Ionis to host 2026 virtual Annual Meeting of Stockholders • Business Wire • 05/04/2026 11:05:00 AM
- Ionis to present at upcoming investor conferences • Business Wire • 05/01/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 06:33:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:00:32 AM
- Ionis reports first quarter 2026 financial results and highlights progress on key programs • Business Wire • 04/29/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/28/2026 08:12:39 PM
- Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B • Business Wire • 04/28/2026 06:06:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 08:22:45 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 11:00:40 AM
- Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting • Business Wire • 04/21/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/16/2026 10:49:36 PM
